Clinical trial
Genetic Association Studies of Diabetic Retinopathy (1): Vanguard Phase
NCT01298245 is registered in ClinicalTrials.gov with Taipei Veterans General Hospital, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Association Studies of Diabetic Retinopathy (1): Vanguard Phase
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 28, 2011
- Completion date
- December 31, 2012
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes, diabetic retinopathy